Filing Details
- Accession Number:
- 0001181431-11-022859
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2011-04-06 18:00:28
- Reporting Period:
- 2011-03-29
- Filing Date:
- 2011-04-06
- Accepted Time:
- 2011-04-06 18:00:28
- Original Submission Date:
- 2011-03-31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1226616 | Medicinova Inc | MNOV | Pharmaceutical Preparations (2834) | 330927979 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1295678 | William Kirk Johnson | C/O Medicinova, Inc. 4350 La Jolla Village Drive, Suite 950 San Diego CA 92122 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-03-29 | 1,700 | $0.00 | 1,700 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrants (Right to Buy) | Acquisiton | 2011-03-29 | 1,700 | $0.00 | 1,700 | $3.56 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,700 | 2011-03-29 | 2016-03-29 | No | 4 | P | Direct |
Footnotes
- This amended Form 4 is being filed to correct the number of Units reported, which was overstated on the prior report.
- The reported securities were included within Units of the Issuer's securities purchased by the reporting person for $3.00 per Unit. Each Unit consists of one share of common stock and one warrant to purchase one share of the Issuer's common stock.